Peptide Knowledge Base · GH-axis
Sermorelin: what it is, what the evidence says, and its real status
A peptide that nudges your body's own growth-hormone axis.
Short version: a GHRH analog that nudges your own growth-hormone rhythm for recovery, muscle, and sleep. Available now, clinician-supervised, and legally stable, the legal GH-axis answer.
Can you actually get it?
Plain-English verdict: Available.
Regulatory status: 503A eligible · Compoundable now.
Available now, clinician-supervised. It is the legal GH-axis answer where CJC-1295 and Ipamorelin are not, those remain FDA Category 2, education-only.
How does Sermorelin work?
Sermorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH 1–29). It signals the pituitary to produce and release the body's own growth hormone, rather than introducing growth hormone directly.
What it does — and what it does not do
What it does: Used to support muscle, recovery, and sleep quality.
What it does not do: It is not anabolic steroid therapy and is not a guaranteed performance enhancer.
How honest is the evidence?
Evidence grade C — moderate clinical history as a GHRH analog; outcome data is limited. Read our grading methodology for what each grade means.
What we still don't know: Long-term outcome data is limited; effects vary with age and baseline.
WADA status: Banned (S2).
How it is taken
Clinician-set; typically evening subcutaneous.
Who should not take it
Banned in tested sport (WADA S2). Discuss active malignancy and pituitary history with a clinician.
Sources
Walker, sermorelin / GHRH-analog clinical reviews · FDA labeling history (Geref)
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker or the knowledge base.
Last reviewed 2026-08-11 · Peptós.LIFE · Not medical advice.